Dissociation of Vasospasm and Secondary Effects of Experimental Subarachnoid Hemorrhage by Clazosentan

Uncoupling of Endothelial Nitric Oxide Synthase after Experimental Subarachnoid Hemorrhage

(2010) Mohammed Sabri et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review

(2010) C. E. Lovelock et al.   NEUROLOGY

Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage

(2009) J. P. Dreier et al.   BRAIN

Anterior circulation mouse model of subarachnoid hemorrhage

(2009) Mohammed Sabri et al.   BRAIN RESEARCH

Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought

(2009) Ryszard M. Pluta et al.   NEUROLOGICAL RESEARCH

Do Endothelin-Receptor Antagonists Prevent Delayed Neurological Deficits and Poor Outcomes After Aneurysmal Subarachnoid Hemorrhage?

(2009) Andreas Kramer et al.   STROKE

Clazosentan, an endothelin receptor antagonist, prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage: a laser Doppler flowmetry study in rats

(2008) Gerrit A. Schubert et al.   JOURNAL OF NEUROSURGERY

Metaanalysis of Tirilazad Mesylate in Patients with Aneurysmal Subarachnoid Hemorrhage

(2008) Yeon Gyoe Jang et al.   Neurocritical Care

Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1)

(2008) R. Loch Macdonald et al.   STROKE